Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8569166 | 0.81 | PTGS2 (0.49) | PTGS2MAOBCYP11B2CYP11B1GPR84 | |
| SCHEMBL30661162 | 0.81 | PTGS2 (0.49) | PTGS2MAOBCYP11B2CYP11B1GPR84 | |
| SCHEMBL4304595 | 0.79 | PTGS2 (0.42) | PTGS2MAOAMAOBKDM4EALDH1A1 | |
| SCHEMBL23234275 | 0.79 | CYP3A4 (0.45) | PTGS2KDM4EALDH1A1MAPK1 | |
| SCHEMBL6907494 | 0.78 | PTGS2 (0.41) | PTGS2MAOAMAOBACHECYP11B2 | |
| SCHEMBL19979197 | 0.78 | PTGS2 (0.41) | PTGS2MAOAMAOBACHECYP11B2 | |
| SCHEMBL8208607 | 0.78 | PTGS2 (0.41) | PTGS2MAOAMAOBACHECYP11B2 | |
| SCHEMBL7423243 | 0.78 | PTGS2 (0.41) | PTGS2MAOAMAOBACHECYP11B2 | |
| SCHEMBL7178730 | 0.77 | PTGS2 (0.40) | PTGS2MAOAMAOBACHECYP11B2 | |
| SCHEMBL4442002 | 0.75 | MAOA (0.45) | PTGS2MAOAMAOBGPR84KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514105-B2 | Fullerene derivative blends, methods of making and uses thereof | NANO-C, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20240423084-A1 | FULLERENE DERIVATIVE BLENDS, METHODS OF MAKING AND USES THEREOF | NANO-C, INC. | 2024-12-19 | — | — | US | disclosed |
| US-12114559-B2 | Fullerene derivative blends, methods of making and uses thereof | NANO-C, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| US-20230309372-A1 | FULLERENE DERIVATIVE BLENDS, METHODS OF MAKING AND USES THEREOF | NANO-C, INC. | 2023-09-28 | — | — | US | disclosed |
| US-11706971-B2 | Fullerene derivative blends, methods of making and uses thereof | NANO-C, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-20220293860-A1 | FULLERENE DERIVATIVE BLENDS, METHODS OF MAKING AND USES THEREOF | NANO-C, INC. | 2022-09-15 | — | — | US | disclosed |
| US-11296278-B2 | Fullerene derivative blends, methods of making and uses thereof | NANO-C, INC. (US) | 2022-04-05 | — | — | US | disclosed |
| US-6087292-A | Metallocene catalysts comprising indenyl ligands substituted with electronegative groups | TANGOR GMBH (DE) | 2000-07-11 | — | — | US | disclosed |
| US-5763542-A | Process for the preparation of an olefin polymer using specific metallocenes | TARGOR GMBH (DE) | 1998-06-09 | — | — | US | disclosed |
| US-5504232-A | Process for the preparation of an olefin polymer using specific metallocenes | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-04-02 | — | — | US | disclosed |
| EP-0582195-A1 | Process for the preparation of polymers using specific metallocenes | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12514105-B2 | Fullerene derivative blends, methods of making and uses thereof | FLNB, FLNA, CYP1B1 | PTGS2 1804/4885MAOA 489/4885MAOB 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.